Basel Medical Group Ltd Ordinary Shares Cash Flow Conversion Efficiency
Basel Medical Group Ltd Ordinary Shares cash flow conversion efficiency. Based on the latest financial reports, Basel Medical Group Ltd Ordinary Shares (BMGL) has a cash flow conversion efficiency ratio of -0.250x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.63 Million) by net assets ($6.52 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Basel Medical Group Ltd Ordinary Shares (2022–2025)
Cash flow conversion efficiency of Basel Medical Group Ltd Ordinary Shares from 2022 to 2025. This chart illustrates how Basel Medical Group Ltd Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Basel Medical Group Ltd Ordinary Shares stock price for real-time trading data and today's change.
Basel Medical Group Ltd Ordinary Shares Cash Flow Conversion Ratio Explained
Basel Medical Group Ltd Ordinary Shares cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Basel Medical Group Ltd Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Basel Medical Group Ltd Ordinary Shares ranked by their cash flow conversion efficiency. Also see market cap of Basel Medical Group Ltd Ordinary Shares for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hanwha Corp. Pfd. Series 1
KO:000885
|
0.114x |
|
Jiankun International Bhd
KLSE:8923
|
-0.018x |
|
RealTech AG
XETRA:RTC
|
0.171x |
|
Impex Ferro Tech Limited
NSE:IMPEXFERRO
|
0.001x |
|
PT Sunter Lakeside Hotel Tbk
JK:SNLK
|
0.004x |
|
Dongil Steel Co. Ltd
KQ:023790
|
-0.014x |
|
Finetek Co. Ltd
KQ:131760
|
0.090x |
|
BRITANNIA LIFE SCIENCES
F:L020
|
0.057x |
Annual Cash Flow Conversion Efficiency for Basel Medical Group Ltd Ordinary Shares (2022–2025)
The table below shows the annual cash flow conversion efficiency of Basel Medical Group Ltd Ordinary Shares from 2022 to 2025. Review free cash flow generation of Basel Medical Group Ltd Ordinary Shares to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $4.86 Million | $-4.34 Million | -0.893x | -369.11% |
| 2024-06-30 | $7.56 Million | $2.51 Million | 0.332x | -29.94% |
| 2023-06-30 | $5.49 Million | $2.60 Million | 0.474x | -37.14% |
| 2022-06-30 | $3.71 Million | $2.79 Million | 0.754x | -- |
About Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental he… Read more